PedAM
Pediatric Disease Annotations & Medicines
| Disease | arteriosclerosis |
| Symptom | |diabetes |
| Sentences | 196 |
| PubMedID- 21359834 | The approach (assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history) study was a double-blind randomized clinical trial comparing the effects of rosiglitazone with glipizide on the progression of coronary atherosclerosis . |
| PubMedID- 23324539 | On the contrary, when compared with the non-ketotic type 2 diabetes, the risk of carotid atherosclerosis was not markedly increased or decreased in the ketosis-onset diabetes. |
| PubMedID- 22576258 | The pathophysiology of atherosclerosis development in patients with diabetes mellitus (dm) is similar to that in nondiabetics. |
| PubMedID- 20361178 | This pathogenic sequence establishes the molecular basis linking insulin resistance, inflammation and accelerated atherosclerosis in people with type 2 diabetes mellitus and may help account for the missing 30% cvd risk that cannot be explained by circulating cardiovascular risk factors (fig. |
| PubMedID- 23375680 | Conclusion: reduction of glucose excursion due to dpp-iv inhibitors administration, may prevent atherosclerosis progression in patients with type 2 diabetes probably through the reduction of daily inflammation and oxidative stress. |
| PubMedID- 22547909 | At the moment the reasons for the increased predisposition and progression of atherosclerosis in patients with diabetes are unknown. |
| PubMedID- 25602196 | While in human atherosclerosis study, in patients with type 2 diabetes, an average annual increase of imt 0.02 mm/year has been reported . |
| PubMedID- 20580029 | Faster progression of coronary atherosclerosis in women with diabetes could be mediated in part by a worse lipoprotein profile in these women than in women without diabetes, both before and during hrt. |
| PubMedID- 23675198 | Although the exact cause of premature atherosclerosis in diabetes is not well understood, several independent risk factors such as hypertriglyceridemia and hypertension may contribute to coronary heart disease (8). |
| PubMedID- 24799979 | Instead, traditional cvd risk factors, age, gender, obesity, and diabetes, were significant determinants of subclinical atherosclerosis, accounting for 29.2% of cimt variability. |
| PubMedID- 23755169 | diabetes increases atherosclerosis in the descending aorta, but the overall plaque area is lower than in the aortic arch. |
| PubMedID- 23735728 | Type 2 diabetes has been associated with accelerated atherosclerosis (11) and elevated systemic inflammation (12–14). |
| PubMedID- 24656691 | Objective: controversies concerning the association of retinal microvascular abnormalities (rmas) with atherosclerosis in patients with diabetes exist. |
| PubMedID- 22120969 | Glp-1 may prevent or delay the formation of atherosclerosis in diabetes mellitus by improving the function of enos. |
| PubMedID- 22923915 | The increased platelet size may be one factor in the increased risk of atherosclerosis associated with diabetes mellitus and associated vascular complications. |
| PubMedID- 21192815 | Conclusions: right coronary wall cmr in asymptomatic older subjects showed increased coronary atherosclerosis in subjects with type 2 diabetes as well as coronary calcification. |
| PubMedID- 23922864 | Although the precise role of inflammation in the development of diabetic microvascular diseases is still unclear, it is likely that inflammation can accelerate atherosclerosis in patients with diabetes . |
| PubMedID- 24194733 | atherosclerosis in diabetes, though accelerated, does not seem to be very different from atherosclerosis in individuals without diabetes type 2, although certain diabetes-specific factors could contribute to pro-atherogenic immune activation and thus aggravate atherosclerosis and risk of cvd. |
| PubMedID- 21816063 | In conclusion, our data indicate that serum uric acid levels are significantly associated with mets and carotid atherosclerosis in patients with type 2 diabetes, even after adjustment for other potential confounders. |
| PubMedID- 20804545 | In this study we used whole body-mr-angiography (wb-mra) to assess the degree of atherosclerosis in patients with long-standing diabetes and to determine the association between metabolic syndrome (mets) and atherosclerotic burden. |
| PubMedID- 25851542 | suggested that ga was a more valuable index than hba1c for predicting the progression of atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 25992325 | Cardiovascular (cv) complications are an essential causal element of prospect in diabetes mellitus (dm), with carotid atherosclerosis being a common risk factor for prospective crisis of coronary artery diseases and/or cerebral infarction in dm subjects. |
| PubMedID- 22447019 | To clarify the effect of the primary prevention of aspirin therapy in diabetic patients, the relationship between blood pressure (bp) and the incidence of atherosclerotic events was investigated in participants in the japanese primary prevention of atherosclerosis with aspirin for diabetes (jpad) trial. |
| PubMedID- 25422776 | Therefore, early detection of atherosclerosis in individuals with diabetes is crucial in reducing the risk of cardiovascular, cerebrovascular and amputation events. |
| PubMedID- 23678326 | Chronic subclinical inflammation is considered to be important for the initiation and / or progression of atherosclerosis in patients with diabetes mellitus. |
| PubMedID- 22421230 | Objectives: the goal of this study was to characterize the extent and composition of coronary atherosclerosis in patients with diabetes mellitus or the metabolic syndrome (met syn) presenting with acute coronary syndromes (acs). |
| PubMedID- 22738646 | Several adipokines have been reported to promote arterial stiffness, inflammation and atherosclerosis in subjects with diabetes and coronary heart disease. |
| PubMedID- 21615922 | In addition to the well-known diabetes-associated risk of coronary atherosclerosis, also metabolic changes and increased triglyceride deposition in the diabetic myocardium are likely to contribute to the development of compromised cardiac function in patients with type 2 diabetes. |
| PubMedID- 25975128 | A relationship between cardiac structural and functional parameters, left ventricular contractility, and coronary atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 22440543 | Periodontitis and diabetes associations with measures of atherosclerosis and chd. |
| PubMedID- 21761004 | The japanese primary prevention of atherosclerosis with aspirin for diabetes (jpad) trial was the first prospective trial to evaluate the use of aspirin (81 or 100 mg) in the primary prevention of ischemic events in diabetic type 2 patients (n = 2,539), aged 30–85 years, in japan . |
| PubMedID- 25120969 | Effect of age and blood pressure on surrogate markers of atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 26466574 | Background: whereas a few studies have reported associations of serum omentin levels with subclinical atherosclerosis in patients with diabetes, little information is available with respect to the associations of serum omentin levels and diabetic microvascular complications. |
| PubMedID- 23124060 | Conclusions: plasma leptin and the leptin/sob-r ratio are associated with atherosclerosis in patients with type 2 diabetes on insulin therapy, and these associations were independent of obesity and other cardiovascular risk factors. |
| PubMedID- 24152423 | It has been also described that preclinical atherosclerosis is associated with type 1 diabetes in young adults and with gestational diabetes , showing an increased c-imt in these patients comparing it to controls. |
| PubMedID- 24768387 | Rationale and design of a study to evaluate the effects of sitagliptin on atherosclerosis in patients with diabetes mellitus: prologue study. |
| PubMedID- 22148131 | The risk factors for atherosclerosis including diabetes mellitus hypertension, hyperlipidemia and smoking were not determined in his past medical history and laboratory analysis. |
| PubMedID- 21525447 | Recently, results of the japanese primary prevention of atherosclerosis with aspirin for diabetes trial showed that, after a median follow-up of 4.37 years, aspirin therapy was associated with a (nonsignificant) 20% reduction (hazard ratio 0.80 ) in the risk of the primary composite end point, including fatal or nonfatal ischemic heart disease, fatal or nonfatal stroke, transient ischemic attack, and peripheral arterial disease (12). |
| PubMedID- 20672024 | The comparison of pioglitazone versus glimepiride on progression of coronary atherosclerosis in patients with type-2 diabetes; the periscope trial , randomized 543 patients with cad and type-2 diabetes to receive one of the two commonly prescribed oral hypoglycemic agents, pioglitazone or glimipride. |
| PubMedID- 25889082 | Serum angptl2 concentration was significantly and positively associated with carotid atherosclerosis in patients with type 2 diabetes, suggesting that angptl2 may be important in the atherosclerosis in humans. |
| PubMedID- 21658276 | Stimuli known to accelerate atherosclerosis in diabetes, such as oxidized ldls, ages, hypoxiacould role as antigens to induce dcs to adhesion to and transmigration through endothelial cells. |
| PubMedID- 21816064 | Among them, high glucose-induced endothelial cell apoptosis has been noted in the pathogenesis of the acceleration of atherosclerosis associated with diabetes . |
| PubMedID- 26069232 | Little data exist about the relationship of apoc-iii, triglycerides, and atherosclerosis in patients with type 2 diabetes mellitus (t2dm). |
| PubMedID- 21226273 | atherosclerosis in diabetes begins earlier, is more markedly pronounced and progresses more rapidly. |
| PubMedID- 24943000 | Given the multi-faceted pathogenesis of atherosclerosis in diabetes, it is likely that any intervention to mitigate this risk must address cv risk factors beyond glycemia alone. |
| PubMedID- 24719773 | atherosclerosis was associated with diabetes, hypertension, overweight (bmi 25–29.9), obesity (by bmi ≥ 30), and abdominal obesity when criteria of idf is used (men ≥ 90 cm; female ≥ 80 cm) and mainly with the presence of two or more risk factors (p < 0.001). |
| PubMedID- 22085839 | Synergistic effect between brap polymorphism and diabetes on the extent of coronary atherosclerosis in the chinese population. |
| PubMedID- 26505665 | Method: this case-control study included 596 type 2 diabetes mellitus patients with carotid atherosclerosis and 379 patients without carotid atherosclerosis. |
| PubMedID- 21227528 | Association of serum trail levels with atherosclerosis in patients with type 2 diabetes mellitus. |
| PubMedID- 23724401 | Vitamin d deficiency has been to be associated with cvd risk factors such as hypertension and diabetes mellitus, with markers of subclinical atherosclerosis such as intima-media thickness and coronary calcification as well as with cardiovascular events such as myocardial infarction, stroke and congestive heart failure. |